ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025.

CMO Photo

As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group’s portfolio, including Shonan Beauty Clinic, one of Japan’s largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company’s marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of customer touchpoints, he will work to further strengthen the Group’s global competitiveness and contribute to the sustainable advancement of the medical aesthetics industry.

Mr. Inoue began his career at P&G Japan and has since accumulated decades of experience in brand strategy, organizational management, and integrated marketing centered on digital at leading international companies both in Japan and overseas, including Eli Lilly Japan, Adobe, and KDDI. He is well recognized for his strengths in designing marketing processes and building organizations from a company-wide perspective, as well as his ability to consistently lead initiatives from research and strategy development to the establishment and operation of execution frameworks and various supporting environments. Most recently, he served as CMO at Pioneer Corporation, where he led the launch of the marketing organization, restructuring of the planning and communication areas, and drove the market introduction of new products. Additionally, he has been instrumental in supporting the development of next generation marketers through contributions to marketing publications, speaking at industry conferences, and collaborating with educational institutions.

  • Comment from CEO Yoshiyuki Aikawa
    “We are delighted to welcome Mr. Shinya Inoue as our new CMO. He brings exceptional expertise and a proven track record in brand strategy, organizational development, and integrated digital marketing. His leadership will be instrumental as we continue to expand globally and elevate the value of our brand.”
  • Comment from Shinya Inoue
    “I am truly honored to join SBC Medical at this pivotal moment, as the company enters a new phase of growth following its successful listing on Nasdaq last year. Since opening its first clinic in Fujisawa in 2000, the company has remained steadfast in its commitment to making aesthetic medicine more accessible guided by CEO Aikawa’s vision. By supporting customers in their desire to live confidently and authentically, SBC has transformed medical aesthetics from a luxury into a more approachable part of everyday life. As a member of this visionary team, I am committed to leveraging my experience to help shape a healthier, more transparent market and contribute to the continued success of SBC Medical.”
  • Career History: Shinya Inoue
    April 2004: Joined P&G Japan
    November 2008: Joined Eli Lilly Japan
    April 2010: Joined Adobe Japan
    March 2018: Joined KDDI Corporation
    April 2021: Joined Pioneer Corporation as CMO (Chief Marketing Officer)
    July 2025: Joined SBC Medical as CMO (Chief Marketing Officer)

About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

For more information, visit https://sbc-holdings.com/ 

Contact
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Momoko Morita / Public Relations E-mail: pr@sbc.or.jp

ICR LLC (In the US)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/201c077c-41b2-4182-81ec-69c60713c013


Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.69
+0.14 (0.06%)
AAPL  268.56
+1.12 (0.42%)
AMD  223.55
-6.74 (-2.93%)
BAC  52.02
+0.38 (0.74%)
GOOG  292.99
+8.03 (2.82%)
META  590.32
-7.37 (-1.23%)
MSFT  487.12
-6.67 (-1.35%)
NVDA  186.52
+5.16 (2.85%)
ORCL  225.53
+5.04 (2.29%)
TSLA  403.99
+2.74 (0.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.